Headline
The latest stories from AHA Today.
The NFL Players Association and AHA teamed up on a PSA to encourage individuals to wear masks to protect against COVID-19.
The Centers for Disease Control and Prevention Oct. 22 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on improving clinicians’ understanding the relationship between COVID-19 and the concerns of people who use drugs or who have a substance use disorder.
The AHA released a public service announcement urging the American public not to delay getting the preventive, scheduled and emergency services they need, and noting that hospitals and health systems are always there, ready to care. The PSA, available in English and Spanish, can be adapted by AHA…
A new poll by Gallup is showing sharp declines in Americans’ willingness to be vaccinated for the SARS-CoV-2 coronavirus.
The Food and Drug Administration Oct. 12 issued an emergency use authorization for Abbott Laboratories’ AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test.
Drug maker Johnson & Johnson Oct. 12 announced the pause of its large-scale, pivotal, multi-country phase 3 trial for its JNJ-78436735 COVID-19 vaccine candidate.
The Department of Health and Human Services Oct. 9 published an FAQ saying that providers cannot use COVID-19 Provider Relief Fund distributions to repay payments made under the Centers for Medicare & Medicaid Services’ Accelerated and Advance Payment programs.
The Centers for Medicare & Medicaid Services Oct. 9 announced a crackdown on labs that are testing for COVID-19 without proper Clinical Laboratory Improvement Amendments certification.
The Department of Health and Human Services and the Steven and Alexandra Cohen Foundation Oct. 10 announced the LymeX Innovation Accelerator, a $25 million, public-private partnership to expedite progress and strategically advance solutions to Lyme and other tickborne diseases.
The Department of Health and Human Services Oct. 9 released the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, mapping the next five years of coordinated, strategic federal actions to address antibiotic resistance.